Korea Investment Corp
RPRX icon

Korea Investment Corp’s Royalty Pharma RPRX Stock Holding History

Korea Investment Corp’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4M Buy
256,562
+36,590
+17% +$1.9M 0.03% 428
2026
Q1 		$10.6M Sell
219,972
-46,800
-18% -$2.05M 0.02% 510
2025
Q4 		$10.3M Buy
266,772
+78,000
+41% +$2.97M 0.02% 504
2025
Q3 		$6.66M Buy
188,772
+53,500
+40% +$1.94M 0.01% 560
2025
Q2 		$4.87M Sell
135,272
-160,900
-54% -$5.33M 0.01% 610
2025
Q1 		$9.22M Buy
296,172
+71,900
+32% +$2.28M 0.02% 520
2024
Q4 		$5.72M Buy
224,272
+68,300
+44% +$1.81M 0.01% 607
2024
Q3 		$4.41M Sell
155,972
-41,393
-21% -$1.15M 0.01% 599
2024
Q2 		$5.2M Sell
197,365
-5,218
-3% -$145K 0.01% 572
2024
Q1 		$6.15M Sell
202,583
-150,506
-43% -$4.44M 0.02% 543
2023
Q4 		$9.92M Buy
353,089
+126,436
+56% +$3.47M 0.03% 467
2023
Q3 		$6.15M Buy
226,653
+188,754
+498% +$5.61M 0.02% 474
2023
Q2 		$1.17M Sell
37,899
-30,513
-45% -$1.03M ﹤0.01% 711
2023
Q1 		$2.46M Buy
68,412
+4,188
+7% +$155K 0.01% 646
2022
Q4 		$2.54M Buy
64,224
+13,737
+27% +$573K 0.01% 659
2022
Q3 		$2.03M Buy
50,487
+24,864
+97% +$1.06M 0.01% 675
2022
Q2 		$1.08M Buy
25,623
+7,023
+38% +$288K ﹤0.01% 712
2022
Q1 		$725K Buy
+18,600
New +$730K ﹤0.01% 714
2021
Q2 		– Sell
-1,400
Closed -$61K – 753
2021
Q1 		$61K Sell
1,400
-39,400
-97% -$1.87M ﹤0.01% 714
2020
Q4 		$2.04M Buy
+40,800
New +$1.73M 0.01% 656

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Korea Investment Corp's RPRX Position: Q2 2026 in Review

Korea Investment Corp increased its Royalty Pharma (RPRX) stake by 17% in Q2 2026, buying an estimated $1.9M and bringing the position to 256,562 shares worth $14.4M. The position accounts for 0.03% of the portfolio, ranked #428.

Korea Investment Corp first reported a position in RPRX in Q4 2020 and has held it in 20 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Korea Investment Corp held 256,562 shares of Royalty Pharma worth $14.4M as of Q2 2026.
  • Korea Investment Corp bought 36,590 Royalty Pharma shares in Q2 2026, an estimated $1.9M.
  • Royalty Pharma made up 0.03% of Korea Investment Corp's portfolio in Q2 2026, its #428 holding.
  • Korea Investment Corp first reported a position in Royalty Pharma in Q4 2020 and has held it in 20 quarters since.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Korea Investment Corp's 13F filing for Q2 2026, filed 12 Aug 2026.